knowcompoundsO-acetyl-(R)-carnitine
Specimen compound organic compoundPlate I
O- acetyl- (R)- carnitine
An acetic acid ester of carnitine that facilitates movement of acetyl COA into the matrices of mammalian mitochondria during the oxidation of fatty acids.”

432 readings, by contour and atom
- Formula
- C9H17NO4
- Molar mass
- 203.238 g/mol
- ChEBI
- CHEBI:57589
- PubChem CID
- 7045767
- MeSH
- D000108
- InChIKey
- RDHQFKQIGNGIED-MRVPVSSYSA-N
– no difference found 4 findings in 4 endpoints
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 4
- Limited
- 0
- Very limited
- 0
- Insufficient
- 0
O-acetyl-(R)-carnitine
Most findings
- HDL cholesterol×1
- LDL cholesterol×1
- Total cholesterol (TC)×1
- Triglycerides×1
17 reference statements, not drawn · 36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · findings
What O-acetyl-(R)-carnitine moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- TriglyceridesMoved: no difference foundEvidence: ModeratePaper: PMID 296962412018
- Who
- Adults over 40 with type 2 diabetes, hypertension and dyslipidemia, all on simvastatin 10 to 20 mg/d in both arms; ALC 116 and placebo 113 randomised; 6 months
- Dose studied
- acetyl-L-carnitine 1000 mg orally twice daily for 6 months
The effect of ALC on triglycerides, lipoprotein(a), LDL, HDL, and total cholesterol was not significantly different from that of placebo.”
Quoted verbatim from Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial.RCT · 6 monthsPermalink - HDL cholesterolMoved: no difference foundEvidence: ModeratePaper: PMID 296962412018
- Who
- Adults over 40 with type 2 diabetes, hypertension and dyslipidemia, all on simvastatin 10 to 20 mg/d in both arms; ALC 116 and placebo 113 randomised; 6 months
- Dose studied
- acetyl-L-carnitine 1000 mg orally twice daily for 6 months
The effect of ALC on triglycerides, lipoprotein(a), LDL, HDL, and total cholesterol was not significantly different from that of placebo.”
Quoted verbatim from Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial.RCT · 6 monthsPermalink - LDL cholesterolMoved: no difference foundEvidence: ModeratePaper: PMID 296962412018
- Who
- Adults over 40 with type 2 diabetes, hypertension and dyslipidemia, all on simvastatin 10 to 20 mg/d in both arms; ALC 116 and placebo 113 randomised; 6 months
- Dose studied
- acetyl-L-carnitine 1000 mg orally twice daily for 6 months
The effect of ALC on triglycerides, lipoprotein(a), LDL, HDL, and total cholesterol was not significantly different from that of placebo.”
Quoted verbatim from Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial.RCT · 6 monthsPermalink - Total cholesterol (TC)Moved: no difference foundEvidence: ModeratePaper: PMID 296962412018
- Who
- Adults over 40 with type 2 diabetes, hypertension and dyslipidemia, all on simvastatin 10 to 20 mg/d in both arms; ALC 116 and placebo 113 randomised; 6 months
- Dose studied
- acetyl-L-carnitine 1000 mg orally twice daily for 6 months
The effect of ALC on triglycerides, lipoprotein(a), LDL, HDL, and total cholesterol was not significantly different from that of placebo.”
Quoted verbatim from Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial.RCT · 6 monthsPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · identity
Structure
- Charge
- 0
- SMILES
- CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C
04 · reach
What it touches on the way
7 entities · assembled from reference reactions
Where it reaches
17 regions · transporter routes
- Colon and rectumdigestive2 routesinferred
- Skeletal musclemusculoskeletal2 routesinferred
- Airway and sinusesrespiratory1 routeinferred
- Bladderurinary1 routeinferred
- Blood and immuneimmune1 routeinferred
- Brainnervous1 routeinferred
- Female reproductivereproductive1 routeinferred
- Gallbladderdigestive1 routeinferred
- Heartcardiovascular1 routeinferred
- Liverdigestive1 routeinferred
- Male reproductivereproductive1 routeinferred
- Mouth and oesophagusdigestive1 routeinferred
Show the remaining 5Show the first 12
- Pancreasendocrine1 routeinferred
- Skinintegumentary1 routeinferred
- Small intestinedigestive1 routeinferred
- Stomachdigestive1 routeinferred
- Thyroidendocrine1 routeinferred
What the reference databases state
17Reference statements
What the reference databases state
Evidence keyStatements
17 statements
Sources: Human-GEM, Rhea
- L-carnitine is converted to O-acetyl-(R)-carnitineCompoundRhea RHEA:21136Inferred only
- O-acetyl-(R)-carnitine is a substrate of CPT1AProteinHuman-GEM MAR02591Inferred only
- O-acetyl-(R)-carnitine is a substrate of CPT1BProteinHuman-GEM MAR02591Inferred only
- O-acetyl-(R)-carnitine is a substrate of CPT1CProteinHuman-GEM MAR02591Inferred only
- O-acetyl-(R)-carnitine is a substrate of CPT2ProteinHuman-GEM MAR02593Inferred only
- O-acetyl-(R)-carnitine is a substrate of CRATProteinHuman-GEM MAR02780, MAR02593, MAR03030Inferred only
- O-acetyl-(R)-carnitine is transported by CRATProteinHuman-GEM MAR03029Inferred only
- O-acetyl-(R)-carnitine is transported by SLC22A15ProteinRhea RHEA:74319Inferred only
- O-acetyl-(R)-carnitine is transported by SLC22A5ProteinHuman-GEM MAR02778, MAR09912 · Rhea RHEA:72099Inferred only
- O-acetyl-(R)-carnitine is transported by SLC25A20ProteinRhea RHEA:49908 · Human-GEM MAR02592, MAR00060, MAR04645Inferred only
16Reactions
06 · on the label · 1,313 products
Labelled products
Source: NIH DSLD · Ingredient: O-acetyl-(R)-carnitine · 1,313 products · Declared amount per serving (the first 1,000 shown): 5–4,000 mg · 3 amounts above the serving weight, left out
749 labels of the first 1,000 shown state an amount251 do not
- 'Merica LabzUncle BAM500 mgper 2 capsulesDSLD:200684
- 1st Phorm1-Db Goddess200 mgper 2 capsulesDSLD:276835
- 1st Phorm1-Db Overdrive200 mgper 2 capsulesDSLD:288071
- 1st PhormThyro-Drive400 mgper 2 capsulesDSLD:276836
- 4 OrganicsJumpstart Boost Formula EX10 mgper 1 capsuleDSLD:268152
- 4 OrganicsJumpstart Boost Formula EX10 mgper 1 capsuleDSLD:268153
- 4LifeRenuvoAcetyl-L-Carnitine HClamount not statedper 2 capsulesDSLD:301054
- Absorb HealthAcetyl L-Carnitine 500 mg500 mgper 1 capsuleDSLD:215997
- Activate SupplementsWave Blueberry Lemonade2 gper 10.95 gDSLD:320871
- Adaptogen ResearchATP Natural Citrus FlavorAcetyl-L-Carnitine Hydrochlorideamount not statedper 7.9 gDSLD:307146
- AddrenaNootropic Stimulant50 mgper 1 tabletDSLD:206821
- AddrenaNootrostimAcetyl-L-Carnitine, as Acetyl-L-Carnitine HCl100 mgper 1 capsuleDSLD:206845
Show the remaining 1,301Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
07 · the record
Sources
103
papers screened for O-acetyl-(R)-carnitine
- admitted
- 1
- read and discarded
- 73
- not read yet
- 29
Sources cited
1 paper · 4 findings
Show every paper citedHide the papers cited
Other names · 11
(-)-Acetylcarnitine · (3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate · (R)-Acetylcarnitine · Acetyl-L-(-)-carnitine · Acetyl-L-carnitine · CAR 2:0 · L-Acetylcarnitine · L-Carnitine acetyl ester · L-O-Acetylcarnitine · R-Acetylcarnitine
systematic · (3R)-3-(acetyloxy)-4-(trimethylazaniumyl)butanoate